Center de Lutte Contre le Cancer (CLCC)

Caen, Calvados 14076

0 studies enrolling now · 1 studies all time

What they study most

HER-2 Positive Breast Cancer, Metastatic Neoplasm

Studies at this site

• Margetuximab Plus Chemotherapy vs Trastuzumab Plus Chemotherapy in the Treatment of HER2+ Metastatic Breast Cancer — Completed